ClinicalTrials.Veeva

Menu
M

Matrix Clinical Research | Los Angeles, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ozanimod
Ritonavir
Linzagolix
Nirmatrelvir
Nimenrix
EVO100
MR-100A-01

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 21 total trials

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

The purpose of this study is to assess the safety and immunogenicity of mRNA-1365, an mRNA vaccine targeting respiratory syncytial virus (RSV) and hu...

Active, not recruiting
Human Metapneumovirus
Respiratory Syncytial Virus
Biological: Placebo
Biological: mRNA-1345

The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth an...

Active, not recruiting
Contraception
Combination Product: Radiopaque Etonogestrel (ENG) Implant

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Enrolling
Acute Gastroenteritis
Norovirus Acute Gastroenteritis
Biological: mRNA-1403
Biological: Placebo

The purpose of this clinical trial is to learn about how study medicine (Paxlovid, which contains nirmatrelvir and ritonavir) is changed and eliminat...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

This study is a Phase III, randomized, single-blind, placebo-controlled, multi-center study to be conducted in healthy infants and toddlers which wil...

Enrolling
RSV Immunization
Biological: Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine
Biological: Streptococcus pneumoniae vaccine

The purpose of this study is to assess the safety and immunogenicity of a single intramuscular (IM) injection of different doses of an respiratory sy...

Active, not recruiting
Healthy Volunteers
Human Metapneumovirus
Biological: RSV/hMPV vaccine candidate Dose B
Biological: RSV/hMPV vaccine candidate Dose A

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Contraception
Drug: MR-100A-01

Trial sponsors

Sanofi logo
Celgene logo
BioNTech logo
Moderna logo
Pfizer logo
Bavarian Nordic logo
E
E
Kissei logo
Mylan logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems